Webb12 juli 2024 · Following the acquisition of these new portfolios, Neuraxpharm’s annual gross sales will be around EUR 0.6 billion. The products benefit patients across a large spectrum of diseases including depression, anxiety, psychosis, alcohol dependence, myasthenia gravis and Parkinson disease. Webb28 mars 2024 · London, UK, 28 March 2024 – Global investment firms PAI Partners and Carlyle (NASDAQ: CG) today announce that they have agreed to acquire Theramex, the leading global specialty pharmaceuticals...
Dilpeche Ramchande - Graduate Financial Analyst
Webb28 mars 2024 · London, UK, 28 March 2024 - Global investment firms PAI Partners and Carlyle (NASDAQ: CG) today announce that they have agreed to acquire Theramex, the leading global specialty pharmaceuticals company focused on women's health, from CVC Capital Partners VI ("CVC"). Theramex was created following the carve-out of a portfolio … WebbTheramex - Sales Statistics Overview; Sales Statistics; Employees Statistics; Unlock the full picture. Number of employees, sales performance and market share of individual … ready for determination
Theramex: Building a dedicated platform for women’s health
WebbTheramex is an international specialty pharmaceutical company with a focus on women’s health. Formed after a divestiture from Teva Pharmaceuticals, it had a short and strict timeframe – less than 12 months – to build its business structure and get its finance, human resources, supply chain and inventory systems up and running. WebbTheramex has been a recognised brand for many decades - but since the purchase of Teva Pharmaceuticals' (Teva) Women's health division in February 2024, Theramex has been … Webb4 sep. 2024 · THERAMEX HQ UK LIMITED is a Private limited company (Ltd.) company based in SLOANE SQUARE HOUSE 1 HOLBEIN PLACE, United Kingdom, which employs 85 people. The company started trading on 4 September 2024. The company registration number is 10944626, It’s main line of business activity is Activities of financial services … ready for dock